Thus, engulfed tumor cells with damaged DNA may activate STING in DCs resulting in IFNβ production functioning in a paracrine or autocrine manner to enhance tumor antigen cross-presentation to T-cells [129,130]. The gene discussed is STING1; the disease is neoplasm.